We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Test Developed for Sickle Cell Anemia

By LabMedica International staff writers
Posted on 20 Sep 2011
A new blood test is being developed, which, for the first time, could help identify babies at risk of a severe form of sickle cell disease. More...


Babies with sickle cell disease have abnormal red blood cells and the test works by detecting these cells, which burst under certain conditions allowing an immediate diagnosis and more intensive treatment to be given.

Scientists from British Universities are collaborating to replace the diagnostic tests for sickle cell disease, which are complicated, requiring skilled technicians, and sophisticated and expensive equipment. Those tests are time consuming and are often not useful in an emergency situation. The newer test involves mixing a blood sample with a special sugar solution in low oxygen. Red blood cells from a baby who has sickle cell disease burst in the liquid, which becomes pink. Cells from a healthy baby do not burst, and the liquid stays clear.

None of the existing tests can predict how severe a baby's illness is likely to be. Babies who are at risk of the most severe symptoms, who might benefit greatly from early and intensive treatment, cannot be easily identified before they become poorly. Children with sickle cell disease face a lifetime of ill health. They have attacks of intense pain called crises, which can last several days. They are prone to infections and anemia, which can be life threatening. They are at risk of a variety of complications, including organ failure, strokes, and leg ulcers, and they have a shortened life expectancy.

An estimated 20 million people are affected worldwide and over 12,000 people in the UK have sickle cell disease, the country's most common severe genetic disorder. Symptoms usually start early in babies who are just six to nine months old. John Gibson, PhD, from the University of Cambridge (UK) is the project leader and working with colleagues at King's College Hospital, (London, UK) have enrolled 120 children and adults with sickle cell disease who will donate blood samples for testing. He said, "The aim of this project is to perfect the diagnostic test, so it can be used routinely at the bedside".

Related Links:
University of Cambridge
King's College Hospital


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.